skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 2
Patent #:
9815813
Issue Dt:
11/14/2017
Application #:
15110504
Filing Dt:
07/08/2016
Publication #:
20170001975
Pub Dt:
01/05/2017
Inventors:
Michael Dore, Rajesh Karki, Matthew J. LaMarche, Martin Sendzik, Zhuoliang Chen et al
Title:
1-(TRIAZIN-3-YL/PYRIDAZIN-3-YL)-PIPER(-AZINE)IDINE DERIVATIVES AND COMPOSITIONS THEREFOR FOR INHIBITING THE ACTIVITY OF SHP2
Assignment: 1
Reel/Frame:
041966/0767Recorded: 04/11/2017Pages: 13
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
CHEN, ZHUOLIANG
Exec Dt:
02/19/2014
DORE, MICHAEL
Exec Dt:
02/19/2014
FORTANET, JORGE GARCIA
Exec Dt:
02/24/2014
KARKI, RAJESH
Exec Dt:
02/24/2014
KATO, MITSUNORI
Exec Dt:
02/21/2014
LAMARCHE, MATTHEW J.
Exec Dt:
02/27/2014
PEREZ, LAWRENCE BLAS
Exec Dt:
02/19/2014
WILLIAMS, SARAH
Exec Dt:
02/21/2014
SENDZIK, MARTIN
Exec Dt:
02/13/2015
Assignee:
NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC.
250 MASSACHUSETTS AVENUE
CAMBRIDGE, MASSACHUSETTS 02139
Correspondent:
DANIEL E. RAYMOND, PH.D.
10675 JOHN JAY HOPKINS DRIVE
SAN DIEGO, CA 92121
Assignment: 2
Reel/Frame:
041966/0906Recorded: 04/11/2017Pages: 5
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC.
Exec Dt:
02/13/2015
Assignee:
NOVARTIS AG
LICHTSTRASSE 35
BASEL, SWITZERLAND 4056
Correspondent:
DANIEL E. RAYMOND, PH.D.
10675 JOHN JAY HOPKINS DRIVE
SAN DIEGO, CA 92121

Search Results as of: 05/15/2024 08:01 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT